Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S373000
Reexamination Certificate
active
07981897
ABSTRACT:
The present invention relates to a hitherto unknown crystal form B of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazin-1-yl]methanone, hydrochloride, to a process for the preparation thereof, and to the use thereof for the preparation of a medicament.
REFERENCES:
patent: 6838461 (2005-01-01), Boettcher et al.
patent: 7084143 (2006-08-01), Boettcher et al.
patent: 2005/0014766 (2005-01-01), van Amsterdam et al.
patent: WO 01/07435 (2001-02-01), None
patent: WO 02/059092 (2002-08-01), None
patent: WO 03/045392 (2004-04-01), None
Brittain “Polymorphism in Pharmaceutical Solids”, vol. 95, Drugs and Pharmaceutical Sciences, 1999.
Amamec R. et al., Prophylactic And Therapeutic Effects Of Acute Systemic Injections Of Emd 281014, A Selective Serotonin 2a Receptor Antagonist On Anxiety Induced By Predator Stress In Rats, European Journal of Pharmacology, Nov. 3, 2004, Amsterdam, NL.
Bathe Andreas
Helfert Bernd
Keiner Ronald
Knierieme Ralf
Saal Christoph
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Sackey Ebenezer
Wilson James O
LandOfFree
Crystal form of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal form of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal form of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2722401